BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Cash Flow 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Cash Flow | -445.9M | -520.7M | -527.7M | -419.5M | -497.9M | -399.7M | -253.6M | -136.6M | -40.5M |
| Depreciation & Amort. | 5.4M | 6.1M | 6.5M | 6.8M | 5.8M | 1.5M | 859,000 | — | — |
| Investing Activities | |||||||||
| Capital Expenditure | 1.1M | 933,000 | 1.3M | 4.8M | 13.2M | 7.5M | 2.6M | 2.2M | 464,000 |
| Free Cash Flow | -447.0M | -521.7M | -529.0M | -424.3M | -511.2M | -407.2M | -256.2M | -138.8M | -41.0M |
| Financing Activities | |||||||||
| Dividends Paid | — | — | — | — | — | — | 997,000 | — | 1.2M |
| Stock Buybacks | 48.3M | 0 | 0 | 0 | 200.0M | 75.0M | — | — | — |
BridgeBio Pharma, Inc. Cash Flow — FAQ
BridgeBio Pharma, Inc. (BBIO) cash flow over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's cash flow history?
The chart and table above show BridgeBio Pharma, Inc.'s cash flow by year and by quarter, including the growth rate.